de.mpg.escidoc.pubman.appbase.FacesBean
Deutsch
 
Hilfe Wegweiser Datenschutzhinweis Impressum Kontakt
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Zeitschriftenartikel

Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking

MPG-Autoren
http://pubman.mpdl.mpg.de/cone/persons/resource/persons50098

Bertram,  L.
Neuropsychiatric Genetics (Lars Bertram), Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society;

Externe Ressourcen
Es sind keine Externen Ressourcen verfügbar
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Sarajarvi, T., Tuusa, J. T., Haapasalo, A., Lackman, J. J., Sormunen, R., Helisalmi, S., et al. (2011). Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking. Molecular and Cellular Biology, 31(11), 2326-40. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21464208 http://mcb.asm.org/content/31/11/2326.full.pdf.


Zitierlink: http://hdl.handle.net/11858/00-001M-0000-0010-7892-8
Zusammenfassung
Agonist-induced activation of the delta-opioid receptor (deltaOR) was recently shown to augment beta- and gamma-secretase activities, which increased the production of beta-amyloid peptide (Abeta), known to accumulate in the brain tissues of Alzheimer's disease (AD) patients. Previously, the deltaOR variant with a phenylalanine at position 27 (deltaOR-Phe27) exhibited more efficient receptor maturation and higher stability at the cell surface than did the less common cysteine (deltaOR-Cys27) variant. For this study, we expressed these variants in human SH-SY5Y and HEK293 cells expressing exogenous or endogenous amyloid precursor protein (APP) and assessed the effects on APP processing. Expression of deltaOR-Cys27, but not deltaOR-Phe27, resulted in a robust accumulation of the APP C83 C-terminal fragment and the APP intracellular domain, while the total soluble APP and, particularly, the beta-amyloid 40 levels were decreased. These changes upon deltaOR-Cys27 expression coincided with decreased localization of APP C-terminal fragments in late endosomes and lysosomes. Importantly, a long-term treatment with a subset of deltaOR-specific ligands or a c-Src tyrosine kinase inhibitor suppressed the deltaOR-Cys27-induced APP phenotype. These data suggest that an increased constitutive internalization and/or concurrent signaling of the deltaOR-Cys27 variant affects APP processing through altered endocytic trafficking of APP.